Operating Lease, Payments of Vitro Biopharma, Inc. from 31 Jan 2022 to 31 Oct 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary: Vitro Biopharma, Inc. annual and quarterly Operating Lease, Payments in USD history and change rate from 31 Jan 2022 to 31 Oct 2025.
Vitro Biopharma, Inc. Operating Lease, Payments for the quarter ending 31 Jan 2025 was $40,757, a 28% decline year-over-year.
Vitro Biopharma, Inc. annual Operating Lease, Payments for 2025 was $164,022, a 9.2% decline from 2024.
Vitro Biopharma, Inc. annual Operating Lease, Payments for 2024 was $180,581, a 35% increase from 2023.
Vitro Biopharma, Inc. annual Operating Lease, Payments for 2023 was $133,598, a 8.3% decline from 2022.
Source SEC data: View on sec.gov

Operating Lease, Payments, Annual (USD)

Operating Lease, Payments, YoY Annual Change (%)

Operating Lease, Payments, Quarterly (USD)

Operating Lease, Payments, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Annual Operating Lease, Payments (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$164,022	-$16,559	-9.2%	01 Nov 2024	31 Oct 2025	10-K	13 Feb 2026	2025	FY
2024	$180,581	+$46,983	+35%	01 Nov 2023	31 Oct 2024	10-K	13 Feb 2026	2025	FY
2023	$133,598	-$12,112	-8.3%	01 Nov 2022	31 Oct 2023	10-K	28 Jan 2025	2024	FY
2022	$145,710			01 Nov 2021	31 Oct 2022	10-K	29 Jan 2024	2023	FY

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$40,757	-$16,189	-28%	01 Nov 2024	31 Jan 2025	10-Q	20 Mar 2025	2025	Q1
Q4 2023	$56,946	+$5,688	+11%	01 Nov 2023	31 Jan 2024	10-Q	20 Mar 2025	2025	Q1
Q4 2022	$51,258	+$31,907	+165%	01 Nov 2022	31 Jan 2023	10-Q	14 Mar 2024	2024	Q1
Q4 2021	$19,351			01 Nov 2021	31 Jan 2022	10-Q	14 Mar 2023	2023	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.